A reviled US pharmaceutical boss who caused a storm in September by jacking up the price of a life-saving drug by 5000 per cent has been arrested on fraud charges.

In New Zealand we have a love/hate relationship with Pharmac, the agency that decides which drugs our Government will pay for.

Two petitions are circulating for the funding of the new immunotherapy drug against melanoma, Keytruda.

Kiwis are waiting for more than 35 cost-effective medicines recommended by a Pharmac advisory committee, a lobby group for the pharmaceutical industry says.

Pharmac is possibly the most publicly respected body in this country.

This NZX-listed healthcare distributor has gone through a meteoric phase of growth, completing roughly 20 acquisitions over the past 10 years.

Pacific Edge widened its first-half loss, spending more on the roll-out of products across America.

The price for one year of perfect health for a NZ patient turned out to be $35,714 in Pharmac's funding of new medicines in the last financial year.

Researchers have developed a protein-based drug that offers a potential breakthrough treatment for those with severe brain and spinal cord injuries.

Tim Groser has a sales job in front of him after the Trans-Pacific Partnership kept the doors open wide to foreign investment in Auckland's red hot housing market.

Most people will be more than aware that, like all public relations campaigns, this one will not reveal the full picture.

FRAN O'SULLIVAN: Geneva has the WTO. Brussels hosts the European Union. Will the Trans-Pacific Partnership put Auckland on the map?

The TPP could be improved after a few years, Trade Minister Tim Groser has said, acknowledging NZ lost against powerful forces that limited dairy sector rewards.

New Zealand and 11 other countries strike Pacific trade pact - a deal that will affect 40 per cent of world's economy.

What deals have other countries by signing up to the TPP deal?

OPINION: Trade Minister conceded a few nasty points but his brinksmanship in TPP negotiations allows him to stare down critics, writes Fran O'Sullivan.

Why everyone is lining up to take a shot at Martin Shkreli.

Turing Pharmaceuticals boss causes global outrage after purchasing the rights to AIDS drug and pushing up the price simply to make a profit.

Adherium wants to raise as much as A$35 million from Australian and Kiwi investors to help fund the commercial roll-out of its product and continue research and development.

Should we be dismayed or relieved at the disarray the Trans-Pacific Partnership negotiations are in? Sorry, but on the information to hand it is impossible to say.

A nurse who stole 5000 vials from a restricted medicine room was able to keep taking the drug because the hospital did not confiscate her ID swipe card.

The first drug that slows down Alzheimer's disease could be available within three years after trials showed it prevented mental decline by a third.

An active ingredient in a cream used to treat head lice and scabies has been linked to causing cancer and will be withdrawn from sale in New Zealand.

It's said to cure women's low libido by making sex more pleasurable. But with fears over side-effects, many doctors are sceptical.

New Zealand is heading towards a two-tier health system, and it could get a whole lot worse, writes George Laking.

Peter Dunne was keen to stress that his approval should not be construed as setting a wider precedent. But how can it not be?

A former pharmacist who was found guilty of selling and supplying drugs to clients had his registration cancelled by the Health Practitioner's Disciplinary Tribunal.

Panadeine, Nurofen Plus and other medicines containing codeine should be banned from over-the-counter sales, say top pain medicine experts.

A promising lung cancer drug has been rescued by a new American sponsor after a potentially disastrous finding of "unacceptable toxicity" in some patients.